Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1

Interventions

Cytarabine 14Methotrexate 12Specimen Handling 10Cyclophosphamide 10venetoclax 8merphos 7fludarabine phosphate 7fludarabine 7Whole-Body Irradiation 7Biopsy 7calaspargase pegol 6blinatumomab 6Vincristine 6Hydrocortisone 6Granulocyte Colony-Stimulating Factor 5Dexamethasone 5Daunorubicin 5Calcium Dobesilate 5Asparaginase 5revumenib 4prednylidene 4deltacortene 4Thioguanine 4Tacrolimus 4Prednisone 4Prednisolone 4N,N-dicyclohexyl-isoborneol-10-sulfonamide 4Mycophenolic Acid 4Methylprednisolone 4Mercaptopurine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Carnitine × 90 days × Clear all
NCT05602194 2026-06-02

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Children's Oncology Group

Phase 3 Active not recruiting
440 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡